Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 1.4%
Wed, 9 Oct 10:31

MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 1.4%Image source: DNY59/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 6% and is presently trading at Rs 298.5.

Meanwhile, the BSE HEALTHCARE index is at 44,566.1 (up 1.4%).

Among the top gainers in the BSE HEALTHCARE index today are Divis Laboratories (up 5.5%) and ERIS LIFESCIENCES (up 3.7%).

SUVEN PHARMACEUTICALS (down 1.8%) and HIKAL CHEMIC (down 0.7%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 105.8 to Rs 298.5, registering a gain of Rs 192.7 (up 182.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,979.6 to 44,566.1, registering a gain of 59.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 174.8%), Glenmark Pharma (up 122.3%) and SUVEN PHARMACEUTICALS (up 106.9%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,965.2 (up 0.4%).

The top gainers among the BSE Sensex today are Bajaj Finance (up 2.6%) and Axis Bank (up 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,117.6 (up 0.4%). Shriram Transport and Trent are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.4 to 81,965.2, registering a gain of 16,452.8 points (up 25.1%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 26.4% YoY to Rs 891 million for the quarter ended June 2024, compared to a profit of Rs 704 million a year ago. Net sales rose 18.1% to Rs 5,906 million during the period as against Rs 5,000 million in April-June 2023.

For the year ended March 2024, MARKSANS PHARMA. reported 18.7% increase in net profit to Rs 3,149 million compared to net profit of Rs 2,653 million during FY23. Revenue of the company grew 17.6% to Rs 21,774 million during FY24.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 40.6.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 1.4%". Click here!